Skip to main content
. 2020 Jun 10;12(3):241–247. doi: 10.4103/UA.UA_89_19

Figure 2.

Figure 2

Forest plots of the included studies assessing. (a) Seroprevalence of parvovirus B19 immunoglobulin G and (b) incidence rate of positive parvovirus B19 DNA in kidney transplant patients. A diamond data marker represents the overall rate from each included study (square data marker) and 95% confidence interval